https://www.selleckchem.com/products/bay-805.html
Repeat therapy with intraperitoneal paclitaxel has been used recently. Intraperitoneal administration of paclitaxel results in prolonged retention in the peritoneal cavity with effects against peritoneal metastases. Repeated administration of paclitaxel does not cause adhesions in the peritoneal cavity. When combination chemotherapy is effective, salvage gastrectomy is a promising option with minimal morbidity and mortality. CONCLUSION Combined chemotherapy with intraperitoneal paclitaxel and systemic chemotherapy followed by gastrectom
Aimer
Commentaire
Partagez
